$OXM

Oxford Industries Q2 Earnings Call Highlights

Oxford Industries (OXM) reported Q2 sales growth at Tommy Bahama offsetting declines elsewhere. Adjusted gross margin rose to 63.1%, while adjusted EBITDA increased to $45M. The company received $42M in tariff refunds, aiding cash flow and debt reduction. Oxford lowered its full-year outlook, expecting a low-single-digit sales decline and adjusted EPS of $1.60-$2.00. Lilly Pulitzer's reset is planned for spring 2027, with targeted promotions expected to support inventory sell-through.

Original reporting
Published Sep 5, 2026, 5:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 5, 2026, 6:19 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Oxford Industries Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$OXMNeutralMed
01

Why it matters

The earnings release provides fresh guidance on sales and EPS, influencing valuation models.

02

Market read

First‑report earnings and guidance for a mid‑cap consumer discretionary stock.

03

What to watch

Tariff refunds boost cash flow; new store conversions may improve profitability later.

Relevance 8/10Novelty 8/10Timing: post‑Q2 earnings release

Background

Oxford Industries operates multiple lifestyle apparel brands; Q2 results include tariff refund impact and operational cost changes.

Company-level read

Ticker impact

$OXMNeutralMedium confidence
Context

Oxford Industries reported Q2 results with adjusted EPS $1.34, raised full-year EPS guidance to $1.60‑$2.00 and lowered full-year sales outlook.

Expected impact

Potential short‑term downside on sales guidance, with upside if margin improvements exceed expectations.

Evidence & confidence

Guidance revision is material; investors will weigh higher margins against lower sales growth.

Market effects

Signals pressure on apparel retail sector earnings outlook, may affect peers.

Impacts US consumer discretionary market sentiment.

Limited to US apparel retailers.

Counterpoint

Margin expansion could offset sales decline, supporting a buy‑on‑dip thesis.

Key entities

  • Oxford Industries

    US‑listed apparel retailer (NYSE:OXM).

Related articles

MedAI 8/10

Oxford Industries, Inc. Q2 2026 Earnings Call Summary

Oxford Industries reported Q2 2026 earnings, with Tommy Bahama showing growth, Lilly Pulitzer struggling due to pricing shifts, and Johnny Was improving profitability. Adjusted gross margin expanded 140 bps. Full-year guidance was lowered due to Lilly Pulitzer's challenges and cautious consumer sentiment. The company plans to reshuffle Lilly Pulitzer's assortment by Spring 2027 and reduce capital expenditures to $60 million. Inventory decreased 4% on a FIFO basis.

$OXMHighAI 8/10

Oxford Industries Shares Fall 14.3% After Full-Year Guidance Cut

Oxford Industries (OXM) shares dropped 14.3% to $31.40 after cutting its full-year earnings forecast. Q2 revenue was $394.4M, beating estimates, but Q3 and full-year guidance fell short. CEO Tom Chubb cited Lilly Pulitzer's weak performance and softer consumer sentiment. OXM shares neared a 52-week low.

$OXMHighAI 8/10

Why Oxford Industries (OXM) Stock Is Falling Today

Oxford Industries (OXM) stock fell 17.7% after reporting Q2 2026 net sales of $394.4M, down 2.2% YoY, and lowering full-year EPS guidance to $1.60-$2.00 due to challenges at Lilly Pulitzer and macroeconomic pressures. Adjusted EPS rose to $1.34, while GAAP EPS included a $2.07 per-share benefit from a tariff refund. Tommy Bahama sales grew 0.8%, but Lilly Pulitzer and Johnny Was saw declines.

$OXMMed

OXM Q2 Deep Dive: Guidance Cut as Lilly Pulitzer Weighs on Mixed Portfolio

Oxford Industries (OXM) met Q2 revenue expectations at $394.4M, down 2.2% YoY, but Q3 guidance of $290M missed estimates by 7.5%. Non-GAAP EPS of $1.34 beat estimates. CEO Thomas Chubb cited strength in Tommy Bahama and challenges at Lilly Pulitzer, including assortment issues and higher promotions. Management expects Lilly Pulitzer's weakness to persist through 2026, with improvements delayed until spring 2027.